13F Data
13F filer · CIK 1833486

Column Group LLC

San Francisco, CA · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$88.1M
$-12.6M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $1.1BQ1 2021: $1.0BQ2 2021: $706.5MQ3 2021: $879.1MQ4 2021: $735.3MQ1 2022: $539.4MQ2 2022: $469.9MQ3 2022: $451.8MQ4 2022: $300.4MQ1 2023: $276.6MQ2 2023: $257.7MQ3 2023: $150.6MQ4 2023: $151.4MQ1 2024: $160.5MQ2 2024: $71.3MQ3 2024: $69.6MQ4 2024: $55.7MQ1 2025: $44.2MQ2 2025: $65.7MQ3 2025: $81.0MQ4 2025: $82.8MQ1 2026: $100.7MQ2 2026: $88.1M
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1Surrozen, Inc.COM1,916,950$49.7M56.46%
2ORIC Pharmaceuticals Inc.COM3,540,777$38.3M43.53%
3Revolution Medicines IncCOM46$8.6K0.01%